A comparative trial of three therapeutic regimens: Ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis

Tropical Doctor

Volumn 39, Issue 4, 2009, Pages 207-210

  Keramat, Fariba ^a   Ranjbar, Mitra ^c   Mamani, Mojgan ^a   Hashemi, Seyyed Hamid ^a   Zeraati, Fatemeh ^b  

^a Department of Infectious Diseases ^*  (United States)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; RIFAMPICIN;

ADULT; ARTICLE; BRUCELLOSIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; EPIGASTRIC DISCOMFORT; FEMALE; FOLLOW UP; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING;

ADULT; ANTI-INFECTIVE AGENTS; BRUCELLOSIS; CIPROFLOXACIN; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE; RIFAMPIN;

EID: 70349336409     PISSN: 00494755     EISSN: 17581133     Source Type: Journal    
DOI: 10.1258/td.2009.090030     Document Type: Article

References (24)

1. Young EJ. Brucella Species. In: Mandel GL, Bennet JE, Dolin R, eds. Mandell, Douglas, and Bennet's Principles and Practice of Infectious Diseases. 6th edn. Philadelphia: Elsevier Churchill Livingstone, 2005:2669-74
2. Salata RA. Brucellosis. In: Goldman L, Bennett Jc, Drazen Jm, eds. Cecil Textbook of Medicine. 21st edn. Philadelphia: W.B.Saunders; 2000:1717-19
3. Jow-Afshani MA, Zowghi E, Simani S, et al., Major Zoonoses in Iran. Tehran: Ministry of Health, 2005. (in Persian)
4. Panahi M. Common Disease Epidemiology in Iran. Medical University of Shahid Beheshti. Tehran: University Publication, 1993. (in Persian)
5. Ariza J, Bosilkovski M, Cascio A, et al., Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med, 2007;4:e317
6. Zowghi E, Ebadi A. Typing of Brucella strains isolated in Iran. Arch Inst Razi, 1997;34:154-5
7. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. New Engl J Med, 2005;352:2325-36
8. Ersoy Y, Sonmez E, Tevfik MR, et al., Comparison of three different combination therapies in the treatment of human brucellosis. Trop Doct, 2005;35:210-2
9. Pappas G, Christou L, Akritidis N, et al., Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect, 2006;12:823-5
10. Alp E, Koc RK, Durak AC, et al., Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis. BMC Infect Dis, 2005;6:72
11. Sauret Jm, Vilissova N. Human brucellosis. J Am Board Fam Pract, 2002;15:401-6
12. Solera J, Martineza-Alfaro E, Espinosa A. Recognition and optimal treatment of brucellosis. Drugs, 1997;53:245-56
13. Doganay M, Ayagen B. Human brucellosis: An overview. Int J Infect Dis, 2003;7:173-82
14. Aygen B, Doganay M, Sumerkan B, et al., Clinical manifestations, complications and treatment of brucellosis: an evaluation of 480 patients. Med Mal Infect, 2002;32:485-93
15. Bosilkovski M, Krteva L, Dimzova M, et al., Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, aboratory test results, and therapy outcome. Int J Infect Dis, 2007;11:342-47
16. Karabay O, Sencan I, Kayas D, et al., Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial. BMC Infect Dis, 2004;4:18
17. Akova M, Uzun O, Akalin HE, Hayran M, Unal S, Gur D. Quinolones in treatment of human brucellosis:comparative trial of ofloxacin- rifampin versus doxycyclin. Antimicrob Agents Chemother, 1993;37:1831-4
18. Agalar C, Usubutun S, Turkyilmaz R. Ciprofloxacin- rifampicin versus doxycycline and rifampicin in the treatment of Brucellosis. Eur J Clin Microbiol Infect Dis, 1999;18:535-38
19. Ranjbar M, Keramat F, Mamani, et al., Comparison between doxycyclin-rifampin–amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Int J Infect Dis, 2007;11:152-6
20. Doganay M, Aygen B. Use of ciprofloxacin in treatment of brucellosis. Eur J Clin Microbiol Infect Dis, 1992;11:74-5
21. Lang R, Raz R, Sacks T, et al., Failure of prolonged treatment with ciprofloxacin in acute brucellosis. J Antimicrob Chemther, 1990;6:841-6
22. Saltoglu N, Tasova Y, Pinal AS, et al., Efficacy of rifamipicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis. Saudi Med J, 2002;23:921-4
23. Solera J, Rodriguez-zapata M, Geijo P, et al., Doxycycline–rifampin versus doxycycline-streptpmycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother, 1995;39:2061-7
24. Solera J, Geijo P, Largo J, et al., A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clin Infect Dis, 2004;39:1776-82